Log in

ASX:M7TMach7 Technologies Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: A$0.57
52-Week Range N/A
Volume272,627 shs
Average VolumeN/A
Market Capitalization$105.13 million
P/E RatioN/A
Dividend YieldN/A
Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. It offers Management Studio that enables healthcare delivery organizations to own, archive, and communicate imaging data from across the enterprise and connect that data with the electronic medical record. The company's Management Studio comprises enterprise imaging platform, vendor neutral archive, communication workflow engine, routing engine, fetching engine, and migration engine products. It also provides Diagnostic Studio that drives specialty workflows. The company's Diagnostic Studio solutions include PACS solution, Universal Worklist, and QC module. In addition, the company offers Clinical Studio, which provides access to view, navigate, review, and share patient medical data over the Web and across the enterprise. Its Clinical Studio solutions consist of clinical portal, clinical viewer, image sharing, and procedure import/export products. Further, the company provides customer training, software installation, and maintenance and support services; and archive migration services. Mach7 Technologies Limited was founded in 2007 and is based in South Burlington, Vermont.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars

Industry, Sector and Symbol

Industry Health Information Services



Sales & Book Value

Annual Sales$14.91 million
Book ValueA$0.18 per share



Market Cap$105.13 million
Next Earnings DateN/A
OptionableNot Optionable

Receive M7T News and Ratings via Email

Sign-up to receive the latest news and ratings for M7T and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Mach7 Technologies (ASX:M7T) Frequently Asked Questions

Has Mach7 Technologies been receiving favorable news coverage?

Headlines about M7T stock have been trending somewhat negative on Tuesday, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mach7 Technologies earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days.
View the latest news about Mach7 Technologies

Who are some of Mach7 Technologies' key competitors?

Who are Mach7 Technologies' key executives?

Mach7 Technologies' management team includes the following people:
  • Mr. Mike Lampron, COO & Interim CEO
  • Mr. Ravi Krishnan, Founder & Chief Strategy Officer
  • Ms. Jennifer Pilcher, Global CFO & Corp. Sec.

What is Mach7 Technologies' stock symbol?

Mach7 Technologies trades on the ASX under the ticker symbol "M7T."

How big of a company is Mach7 Technologies?

Mach7 Technologies has a market capitalization of $0.00 and generates $14.91 million in revenue each year.

What is Mach7 Technologies' official website?

The official website for Mach7 Technologies is www.mach7t.com.

How can I contact Mach7 Technologies?

The company can be reached via phone at 802-861-7745.

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.